The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion
Abstract
We have measured the free and peptide-bound type I collagen cross-link excretions in normal women and in patients with metabolic bone disease using the HPLC technique and immunoassays recognizing specifically the free or peptide-bound forms of pyridinoline (Pyr). After menopause, free deoxypyridinoline (free D-Pyr) excretion measured by HPLC without urine hydrolysis and expressed as a fraction of the total excretion was lower than in premenopausal women (45 ± 15% vs. 59 ± 12%, p > 0.005), whereas the fraction of free Pyr was not changed. In normal pre- and postmenopausal women (n = 43), the fraction of free D-Pyr was negatively correlated with bone turnover rate as assessed by the total urinary excretion of Pyr (r = –0.64, p > 0.001). In patients with a variety of metabolic bone diseases characterized by increased bone turnover (osteoporosis, Paget's disease, and hyperthyroidism), the fractions of free Pyr and free D-Pyr were significantly lower than in premenopausal controls (p > 0.001 for all diseases). After 3 days of intravenous (iv) treatment with the bisphosphonate pamidronate in patients with Paget's disease and osteoporosis, the urinary excretion of cross-linked peptides measured by high performance liquid chromatography (HPLC) or enzyme-linked immunoassay (ELISA) (NTX and CrossLaps) was markedly decreased (–52% and –85% for NTX, –71% and –93% for CrossLaps™ in Paget's disease and osteoporosis, respectively). The excretion of total cross-links was decreased to a lesser extent after treatment (–25% and –25% for total Pyr, –37% and –45% for total D-Pyr) and, surprisingly, free cross-links measured either by HPLC without urine hydrolysis or with an ELISA specific for free D-Pyr were unchanged after treatment. In contrast to bisphosphonate therapy, estrogen treatment of postmenopausal women decreased not only total and cross-linked peptides but also the free cross-link excretion that was reduced by about 30–40%. The different effects of bisphosphonate and estrogen therapy on the excretion of peptide-bound and free cross-link excretion were confirmed by gel filtration of the urine on Sephadex G 25 before and after treatment. In conclusion, we have shown that increased bone turnover in patients with metabolic bone disease could result in a larger increase of the urinary excretion of cross-linked peptides over the increase of free cross-links. Bisphosphonate therapy decreased markedly cross-linked peptides without significant change in free cross-link excretion contrasting with a decrease of both free and peptide-bound cross-links after estrogen therapy. These data suggest that these two antiresorptive therapies may affect differently the pattern of bone collagen degradation, an intriguing possibility that should be further investigated in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Maciewicz, R. A., Wotton, S. F., Etherington, D. J., & Duance, V. C. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81151-d · Cited by 147
Cited by
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Bisphosphonates: mechanisms of action.
Rodan, G. A., & Fleisch, H. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118722 · Cited by 921
Garnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Self-citationBiochemical Markers of Bone Metabolism: An Overview
Christenson, R. H. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00113-6 · Cited by 542
Journal of Bone and Mineral Research
Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081323 · Cited by 454
Self-citation
Metadata
- Authors
- Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., & Delmas, P. D.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-04-01
- Volume
- 10
- Issue
- 4
- Pages
- 641-649
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1975606701
- Cited by
- 216
- References
- 2
- FWCI
- 29.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. https://app.cochat.ai/papers/10.1002/jbmr.5650100418
- The paper
- Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., & Delmas, P. D. (1995). Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650100418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.